Hyperimmunized egg product for treatment of necrotic enteritis in poultry
US11230590B2 · kind B2 · utility
0Cited by
6References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 18, 2019 |
| Grant date | Jan 25, 2022 |
| Priority date | — |
| Expiry date | Sep 18, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/23
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, the present invention is directed to a method for preventing or treating necrotic enteritis by administering a hyperimmunized egg product obtained from an egg-producing animal to an avian. The hyperimmunized egg product may contain an antibody specific to an antigen selected from the group consisting of Clostridium perfringens α-toxin, Clostridium perfringens elongation factor Tu (EF-Tu), Clostridium perfringens necrotic enteritis B-like (NetB) toxin, Clostridium perfringens Pyruvate: Ferredoxin oxidoreductase (PFO), and Eimeria tenella elongation factor 1-alpha.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.